Dougherty's Pharmacy, Inc. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was USD 8.761 million compared to USD 9.947 million a year ago. Operating income was USD 406,000 compared to USD 312,000 a year ago. Net loss was USD 2.483 million compared to USD 436,000 a year ago. Basic loss per share was USD 0.11 compared to USD 0.02 a year ago. For the nine months, sales was USD 27.384 million compared to USD 30.213 million a year ago. Operating income was USD 987,000 compared to USD 485,000 a year ago. Net loss was USD 3.180 million compared to USD 909,000 a year ago. Basic loss per share was USD 0.14 compared to USD 0.04 a year ago.